CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for ADMA Biologics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

ADMA Biologics Inc
465 State Route 17
Phone: (201) 478-5552p:201 478-5552 RAMSEY, NJ  07446  United States Ticker: ADMAADMA
Business Summary
ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The Company manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV (immune globulin intravenous, human - slra 10% liquid) for the treatment of PI, and NABI-HB (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. Through its ADMA BioCenters subsidiary, the Company also operates as an FDA-approved source plasma collector in the United States, which provides its blood plasma for the manufacture of its products.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes---

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research
8099 Health and allied services, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Steven A.Elms 60 1/1/2007
President, Chief Executive Officer, Co-Founder, Director Adam S.Grossman 47 7/24/2024 1/1/2007
Vice Chairman of the Board, Co-Founder Jerrold B.Grossman 76 1/1/2007
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
ADMA BioManufacturing, LLC 5800 Park OF Commerce Blvd Boca Raton​ FL United States

Business Names
Business Name
ADMA
ADMA Bio Centers Georgia Inc.
ADMA BioManufacturing, LLC
ADMA Plasma Biologics, Inc.
BIVIGAM™
Nabi-HB™

General Information
Number of Employees: 624 (As of 12/31/2023)
Outstanding Shares: 236,390,253 (As of 11/1/2024)
Shareholders: 30,000
Stock Exchange: NASD
Federal Tax Id: 562590442
Fax Number: (201) 478-5553


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024